135 related articles for article (PubMed ID: 19228615)
1. Prescribing records and the First Amendment--New Hampshire's data-mining statute.
Post R
N Engl J Med; 2009 Feb; 360(8):745-7. PubMed ID: 19228615
[No Abstract] [Full Text] [Related]
2. Commercial versus social goals of tracking what doctors do.
Grande D; Asch DA
N Engl J Med; 2009 Feb; 360(8):747-9. PubMed ID: 19228616
[No Abstract] [Full Text] [Related]
3. Prescribing records and the First Amendment.
Sullivan LW; Post R
N Engl J Med; 2009 Jul; 361(2):209-10; author reply 210. PubMed ID: 19587351
[No Abstract] [Full Text] [Related]
4. Higher First Amendment hurdles for public health regulation.
Outterson K
N Engl J Med; 2011 Aug; 365(7):e13. PubMed ID: 21812665
[No Abstract] [Full Text] [Related]
5. Prescriptions, privacy, and the First Amendment.
Curfman GD; Morrissey S; Drazen JM
N Engl J Med; 2011 May; 364(21):2053-5. PubMed ID: 21524208
[No Abstract] [Full Text] [Related]
6. A patient's right of privacy in computerized pharmacy records.
Mowery G
Univ Cincinnati Law Rev; 1998; 66(2):697-746. PubMed ID: 16211743
[No Abstract] [Full Text] [Related]
7. Off-label marketing and the First Amendment.
Boumil MM
N Engl J Med; 2013 Jan; 368(2):103-5. PubMed ID: 23234470
[No Abstract] [Full Text] [Related]
8. State loses data-mining case. N.H. plans appeal of ruling allowing use of Rx data.
Conn J
Mod Healthc; 2007 May; 37(20):32. PubMed ID: 17542311
[No Abstract] [Full Text] [Related]
9. For sale: physicians' prescribing data.
Steinbrook R
N Engl J Med; 2006 Jun; 354(26):2745-7. PubMed ID: 16807410
[No Abstract] [Full Text] [Related]
10. Commentary: can we talk? About Food and Drug Regulation and the First Amendment.
Cohen MN
Food Drug Law J; 2003; 58(4):741-56. PubMed ID: 15027458
[No Abstract] [Full Text] [Related]
11. In the interest of privacy. Deborah Peel has some blunt words on the increased push for data-mining.
Conn J
Mod Healthc; 2007 May; 37(20):30-1. PubMed ID: 17542310
[No Abstract] [Full Text] [Related]
12. The First Amendment and federal court deference to the Food and Drug Administration: The Times They Are A-Changin'.
Basile EM; Gross M
Food Drug Law J; 2004; 59(1):31-44. PubMed ID: 15190924
[No Abstract] [Full Text] [Related]
13. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
Javitt GH; Stanley E; Hudson K
Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
[No Abstract] [Full Text] [Related]
14. Pharmaceutical promotion to physicians and First Amendment rights.
Kesselheim AS; Avorn J
N Engl J Med; 2008 Apr; 358(16):1727-32. PubMed ID: 18420505
[No Abstract] [Full Text] [Related]
15. Pharmaceutical promotion and First Amendment rights.
Troy DE; Gottlieb S
N Engl J Med; 2008 Jul; 359(5):536; author reply 536-7. PubMed ID: 18669437
[No Abstract] [Full Text] [Related]
16. Restrictions on the use of prescribing data for drug promotion.
Mello MM; Messing NA
N Engl J Med; 2011 Sep; 365(13):1248-54. PubMed ID: 21812664
[No Abstract] [Full Text] [Related]
17. Forbidden and Permitted Statements about Medications--Loosening the Rules.
Avorn J; Sarpatwari A; Kesselheim AS
N Engl J Med; 2015 Sep; 373(10):967-73. PubMed ID: 26332553
[No Abstract] [Full Text] [Related]
18. Physician specific prescribing information.
Somberg J
Am J Ther; 2006; 13(6):465. PubMed ID: 17122524
[No Abstract] [Full Text] [Related]
19. Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity.
Morag-Sela T; Cohn I; Kowalski TJ; Jarecki-Black J; Clyde-Watson Z
Nat Biotechnol; 2004 Dec; 22(12):1591-2. PubMed ID: 15583670
[No Abstract] [Full Text] [Related]
20. Inconsistent government policies: why FDA off-label regulation cannot survive First Amendment review under Greater New Orleans.
Hall RF; Sobotka E
Food Drug Law J; 2007; 62(1):1-48. PubMed ID: 17444025
[No Abstract] [Full Text] [Related]
[Next] [New Search]
